|
||||
---|---|---|---|---|
Life
SciCon GmbH is a consultant for the Life Sciences Industry and to
Institutional Investors active in this sector. With our expertise in
Molecular Biology and Pharmacology/Toxicology and as acknowledged
professionals in the capital market, we provide our clients with the
highest degree of service and quality.
We are a private Company, independent from Banks and Investment Houses.
With a focus on Equity Research, Corporate Finance & Capital
Markets for Start-up and Small/MidCap situations, especially Growth
Companies, we support management and stakeholders of such companies in
executing their growth and financial strategy. As advisors and
financial analysts, we evaluate companies, provide fairness opinions,
and conduct impairment tests.
Based on the market expertise of our institutional partners, we consult
companies to obtain financing in the Private Equity and public markets.
It is the natural conflict of interests in the capital markets arena
that we understand to moderate based on a fair representation of assets
and resources. As a partner of the Company's management we try to
objectively match interests of banks, issuers, and the investment
community. We secure the quality of our work with high professional
standards and a profound experience pertaining to partners and
employees. Our consulting practices are governed by the DVFA (German
Association of Financial Analysts and Asset Managers).
Our Business Focus
|
||||
Imprint / Impressum Life SciCon GmbH Handelsregister: HRB 51308 Budenheimer Straße 21 • 55124 Mainz •
Germany Geschäftsführender Gesellschafter: Dr.
Roger Becker, CEFA |